全部
logo

Corrigendum to "Lipopolysaccharide-induced podocyte injury is regulated by calcineurin/NFAT and TLR4/MyD88/NF-κB signaling pathways through Angiopoietin-like protein 4" [Genes & Diseases 9(2022) 443-455]

CORRIGENDUM

Corrigendum to "Lipopolysaccharide-induced podocyte injury is regulated by calcineurin/NFAT and TLR4/MyD88/NF-κB signaling pathways through Angiopoietin-like protein 4" [Genes & Diseases 9(2022) 443-455]

Xiujin Shen
Chunhua Weng
Yucheng Wang
Cuili Wang
Shi Feng
Xiayu Li
Heng Li
Hong Jiang
Haibing Wang
Jianghua Chen
Genes & Diseases第9卷, 第6期pp.1757-1758纸质出版 2022-11-01
113600

The authors regret that some statistical errors were made in “Lipopolysaccharide-induced podocyte injury is regulated by calcineurin/NFAT and TLR4/MyD88/NF-κB signaling pathways through Angiopoietin-like protein 4” (Genes Dis, https://doi.org/10.1016/j.gendis.2020.07.005) at Figure 2G, Figure 3B and F, and Figure 4C and D for Angptl4 expression, Figure 5E for CaN expression. For these quantitative results, which should be used with one-way ANOVA statistical methods, but authors wrongly used T-test between two groups during the submission of the original manuscript, and they did not notice these errors during the submission of the original manuscript. Furthermore, the strain of the mice described in the materials and methods should be C57/BL/6 mice. Moreover, in Fig.S3a of the original manuscript, it should be the mRNA expression of CD14, not the mRNA expression of Angptl4. With this change in the figures, the authors confirm that this correction does not alter the conclusions in the manuscript.

pic